All In Biotech

Free tool

FAERS Monitor: Gadavist

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 201277 or its brand name (Gadavist, Gadobutrol). Reports on generic versions are filed under their own applications.

Reports

4,907

Serious

2,187

45% of reports

Hospitalization

734

Death reported

189

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • urticaria1,188
  • nausea890
  • vomiting742
  • pruritus730
  • dyspnoea455
  • erythema375
  • dizziness244
  • rash244
  • cough231
  • headache222
  • throat irritation184
  • contrast media reaction168
  • feeling hot142
  • sneezing141
  • anaphylactic reaction139

Reports by year received

View as table
YearReports
20091
2011103
2012442
2013327
2014364
2015317
2016373
2017414
2018310
2019266
2020177
2021325
2022307
2023330
2024353
2025301
2026197

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,252 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
contrast media reactionSignal168328.5281.550,648
urticariaSignal1,18830.629.134,023
sneezingSignal14127.123.03,501
throat irritationSignal18417.615.32,867
anaphylactic reactionSignal13910.89.21,227
feeling hotSignal1429.98.51,135
pruritusSignal7308.27.64,652
erythemaSignal3757.87.12,246
vomitingSignal7426.86.33,723
nauseaSignal8904.84.52,796
coughSignal2313.53.1422
dyspnoeaSignal4553.43.2809
rashSignal2442.42.1202
dizzinessSignal2442.11.9142
headache2221.51.340

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.